Blog Archives

John Snow Society Pump Handle Lecture Series 2013

Dr. D. A. Henderson explains how a $200 prize in 1950 changed his career path from cardiology to public health. What Dr. Henderson doesn’t say is that his decision not only changed his life, but ultimately changed the course of … Continue reading

Video | Posted on by | Tagged , , , | Leave a comment

New Video Brief: Compensating Victims After a Nuclear Disaster – Ryan Morhard

Center for Biosecurity Associate Ryan Morhard explains the history of public liability insurance in the economics of nuclear power and the role of the Price-Anderson Act in facilitating the unprecedented growth of nuclear power in the US. He then discusses … Continue reading

Video | Posted on by | Leave a comment

Interview with Luciana Borio

http://youtu.be/M9ha3xHlUpg

Luciana Borio, MD

Assistant Commissioner for Counterterrorism Policy and Director, Office of Counterterrorism and Emerging Threats in the Office of the Chief Scientist, US Food and Drug Administration

Description

In this interview, Dr. Borio outlines the evolving role that the Food Drug Administration (FDA) has assumed in the development of medical countermeasures. Under Dr. Borio’s leadership, the FDA has established the Medical Countermeasure Initiative (MCMi), which is an effort to hasten the development of these products, and to improve their odds of achieving FDA approval. The MCMi has made investments in improving the regulatory science that will be necessary for government’s ability to evaluate a new generation of medical products. Here, Dr. Borio discusses some of the successes that the FDA has achieved in this arena, such as the ability to evaluate and approve multiplex diagnostic assays, as well as the challenges that remain.

Video produced by the Center for Biosecurity of UPMC

Continue reading

Video | Posted on by | Leave a comment

Interview with Phyllis Arthur

http://youtu.be/eFDkRPkn8zY

Phyllis Arthur
Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization

Description
The timely availability of medical countermeasures—drugs, vaccines and other medical resources needed for a robust response—is a key component of US biosecurity. Ms. Arthur discusses the role of public-private partnerships in drug and vaccine development and production and broadly outlines the roles that Congress, the Administration, and the private sector play regarding US biodefense policy.

As a senior leader at the Biotechnology Industry Organization (BIO), Ms. Arthur has a unique and critical role at the interface between the resources and requirements of the US government and the research, development, manufacturing, and production capabilities of private industry.

Video produced by the Center for Biosecurity of UPMC

Continue reading

Video | Posted on by | Leave a comment